Metraipolis › archive › dc_c2ce2f0bd66f

Real-World Safety Profile of Spesolimab in Generalized Pustular Psoriasis: Insights From Japan as Part of a Multinational Expanded Access Program (EAP) — Europe PMC PMID:41472501

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41472501
DOI
10.1111/1346-8138.70122
License (as archived)
solo-consultazione
Archived
2026-11-07T07:47:56.190Z
SHA-256 of the archived text
0a7838122fa52a44c8457b1170a9cb165bfe220d1a17f5f86bf81abc30298c03
Stable URL of this page
https://metraipolis.com/documento/dc_c2ce2f0bd66f

How to cite

Real-World Safety Profile of Spesolimab in Generalized Pustular Psoriasis: Insights From Japan as Part of a Multinational Expanded Access Program (EAP) — Europe PMC PMID:41472501 — Europe PMC (en), https://europepmc.org/article/MED/41472501 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c2ce2f0bd66f (Metraipolis archive dc_c2ce2f0bd66f, sha256 0a7838122fa52a44c8457b1170a9cb165bfe220d1a17f5f86bf81abc30298c03)
BibTeX
@misc{dcc2ce2f0bd66f,
  title = {Real-World Safety Profile of Spesolimab in Generalized Pustular Psoriasis: Insights From Japan as Part of a Multinational Expanded Access Program (EAP) — Europe PMC PMID:41472501},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41472501},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c2ce2f0bd66f; sha256 0a7838122fa52a44c8457b1170a9cb165bfe220d1a17f5f86bf81abc30298c03},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41472501. Agents can read the archived copy with the MCP tool read_document.